-
Mashup Score: 10“TEG” talks: technology worth spreading? - 4 month(s) ago
Recently, in Research and Practice in Thrombosis and Haemostasis, Hartmann and colleagues have authored a comprehensive and aesthetically pleasing illustrated review on viscoelastic testing (VET), including thromboelastography (TEG), rotational thromboelastometry (ROTEM), and newer resonance based viscoelastic technologies. They visually describe and discuss viscoelastic technology, its 70-year history and recent growth, its various applications based on existing evidence and clinical case studies, and finally, barriers to widespread adoption and possible solutions to overcome this.
Source: www.rpthjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Background Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respiratory failure, the most common cause of death, in patients with COVID-19. Randomized cont…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A study by @sholzberg & team found that therapeutic #heparin is beneficial in moderately ill patients, but not in severely ill patients, hospitalized with #COVID19. Read it #OpenAccess in @RPTHjournal. #RPTH >> https://t.co/R6f1SGDNGw https://t.co/7dojn4ovGZ
-
-
Mashup Score: 0
Background Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respiratory failure, the most common cause of death, in patients with COVID-19. Randomized cont…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A study by @sholzberg & team found that therapeutic #heparin is beneficial in moderately ill patients, but not in severely ill patients, hospitalized with #COVID19. Read it for free in @RPTHjournal. #RPTH >> https://t.co/R6f1SGDNGw https://t.co/LdpC1pqqzM
-
-
Mashup Score: 1Reproductive issues in women on direct oral anticoagulants - 2 year(s) ago
Direct oral anticoagulants (DOACs) are replacing warfarin and other vitamin K antagonists for a wide range of indications. Advantages of DOAC therapy are fewer food and drug interactions and fixed do…
Source: Wiley Online LibraryCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read this #OpenAccess @RPTHjournal State of the Art Review by Jan Beyer-Westendorf & Sandra Marten. It summarizes the most relevant evidence on reproductive issues in women on direct oral anticoagulants #DOACs. >> https://t.co/0taFH7X6gJ #RPTH #WomensHealth @isth https://t.co/R2xnmdy8Ru
-
-
Mashup Score: 36Milvexian for the Prevention of Venous Thromboembolism | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Milvexian for the Prevention of Venous Thromboembolism
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Important proof-of-concept Phase 2 trial showing efficacy of oral FXAi Milvexian https://t.co/xc7S2c3Lkw @NATFthrombosis @PERTConsortium @ThrombosisUK @EuropeanTHA @AnticoagForum @ThrombosisCan @canvector @isth @escardio #RPTH #thrombosis #ZuckerSOM
-
-
Mashup Score: 2Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? - 2 year(s) ago
Figures (1)KeywordsCOVID-19ThrombosisAnticoagulant therapy1. Why is anticoagulation a therapeutic consideration in patient with COVID-19?Venous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), and arterial thromboembolism (ATE), which includes myocardial infarction, ischemic stroke, systemic embolism, and peripheral arterial events, are common among…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Another reason why the 2021 ASH Guidelines got it wrong: RCT evidence to support therapeutic-dose heparins in COVID-19 ward patients: https://t.co/v1wkGCDRuc @NATFthrombosis @PERTConsortium @ThrombosisUK @EuropeanTHA @AnticoagForum @ThrombosisCan @canvector @isth @escardio #RPTH
-
-
Mashup Score: 1
Background Coronavirus disease 2019 (COVID-19) is associated with activation of coagulation that mainly presents as thrombosis. Sepsis is also associated with activation of coagulation that mainly p…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
'Comparison of the coagulopathies associated with #COVID19 and #sepsis.' Read it #openaccess in #RPTH. >>> https://t.co/9bRyQ6VEGR https://t.co/XYpezjU7y7
-
-
Mashup Score: 0
Background Coronavirus disease 2019 (COVID-19) is associated with activation of coagulation that mainly presents as thrombosis. Sepsis is also associated with activation of coagulation that mainly p…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
'Comparison of the coagulopathies associated with #COVID19 and #sepsis.' Read it #openaccess in @RPTHjournal. #RPTH >>> https://t.co/DWCG01dSBL https://t.co/mjh1H7HTsv
-
-
Mashup Score: 0Aspirin at 120: Retiring, recombining, or repurposing? - 3 year(s) ago
During the past 20 years, we have witnessed the following trends in aspirin usage: (i) a “dropping” trend, characterized by the early discontinuation of low-dose aspirin from dual antiplatelet therap…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Trending article: '#Aspirin at 120: Retiring, recombining, or repurposing?' Read it #openaccess in @RPTHjournal. #RPTH @isth 👉 https://t.co/jf7PosqO13 https://t.co/P5UiVe6HwZ
-
-
Mashup Score: 0
Objective To determine the efficacy and safety of dalteparin postoperative bridging treatment versus placebo for patients with atrial fibrillation or mechanical heart valves when warfarin is temporarily interrupted for a planned procedure. Design Prospective, double blind, randomised controlled trial. Setting 10 thrombosis research sites in Canada and India between February 2007 and March…
Source: The BMJCategories: Hem/Oncs, Latest HeadlinesTweet-
No benefits of Perioperative LMWH bridging in heart valve AND AF patients. Is bridging EVER needed? https://t.co/xAiKBMm5LS #WTD @isth @canvector @EuropeanTHA @NATFthrombosis @ThrombosisUK #ZuckerSOM @AnticoagForum #RPTH #cardiotwitter @ESCCardioReport @ThrombosisCan
-
Congratulations @JanHartmannMD @HermelinMD and @JerroldLevy on an excellent @RPTHjournal illustrated review! Wow #2!! And congratulations @Ritaselby1 on her excellent illustrated commentary of this review (an #rpth first!) https://t.co/l8ItadDd1Y @MaryCushmanMD @ProfMakris https://t.co/pTDNbawogO